Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$5.45 - $7.35 $168,535 - $227,291
30,924 New
30,924 $227,000
Q2 2021

Aug 16, 2021

SELL
$8.81 - $15.03 $1.16 Million - $1.98 Million
-131,981 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$10.02 - $13.92 $51,372 - $71,367
-5,127 Reduced 3.74%
131,981 $1.4 Million
Q4 2020

Feb 16, 2021

BUY
$7.42 - $15.96 $1.02 Million - $2.19 Million
137,108 New
137,108 $1.73 Million

Others Institutions Holding ALPN

About ALPINE IMMUNE SCIENCES, INC.


  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.